Free Trial

Dr. Martens (LON:DOCS) Stock Price Up 0.5% - What's Next?

Dr. Martens logo with Consumer Cyclical background

Dr. Martens plc (LON:DOCS - Get Free Report) shares shot up 0.5% on Friday . The company traded as high as GBX 74.95 ($0.93) and last traded at GBX 73.95 ($0.92). 1,003,337 shares changed hands during trading, an increase of 27% from the average session volume of 792,198 shares. The stock had previously closed at GBX 73.55 ($0.91).

Dr. Martens Stock Up 0.5 %

The company has a market capitalization of £711.19 million, a price-to-earnings ratio of 1,056.43, a P/E/G ratio of 6.40 and a beta of 0.11. The business has a fifty day simple moving average of GBX 65.38 and a two-hundred day simple moving average of GBX 66.30. The company has a quick ratio of 1.13, a current ratio of 2.85 and a debt-to-equity ratio of 129.55.

Dr. Martens Cuts Dividend

The company also recently announced a dividend, which will be paid on Tuesday, April 8th. Stockholders of record on Thursday, March 6th will be issued a GBX 0.85 ($0.01) dividend. This represents a dividend yield of 1.47%. The ex-dividend date is Thursday, March 6th. Dr. Martens's payout ratio is 4,285.71%.

Dr. Martens Company Profile

(Get Free Report)

Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It offers originals, fusion, kids, and casual, as well as accessories. The company offers its products under the Dr. Martens brand name. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.

Read More

Should You Invest $1,000 in Dr. Martens Right Now?

Before you consider Dr. Martens, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dr. Martens wasn't on the list.

While Dr. Martens currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Crypto Boom 2025: Bitcoin’s Rise and Trump’s Impact on the Market
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines